P

Inventor

TURECI OZLEM

DE65 patents
⚠️ This page may combine multiple inventors who share the name “TURECI OZLEM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GANYMED PHARMACEUTICALS AG

13 patents
US10233253B2Mar 19, 2019

Antibodies for treatment of cancer expressing claudin 6

GANYMED PHARMACEUTICALS AG7 citations83
US10053512B2Aug 21, 2018

Antibodies against claudin 18.2 useful in cancer diagnosis

GANYMED PHARMACEUTICALS AG6 citations83
US10314890B2Jun 11, 2019

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic cancer

GANYMED PHARMACEUTICALS AG5 citations82
US9770487B2Sep 26, 2017

Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma

GANYMED PHARMACEUTICALS AG11 citations82
US10813996B2Oct 27, 2020

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

GANYMED PHARMACEUTICALS AG4 citations81
US9775785B2Oct 3, 2017

Antibody to genetic products differentially expressed in tumors and the use thereof

GANYMED PHARMACEUTICALS AG5 citations81
US8961980B2Feb 24, 2015

Monoclonal antibodies for treatment of cancer

GANYMED PHARMACEUTICALS AG5 citations79
US10022444B2Jul 17, 2018

Combination therapy involving antibodies against Claudin 18.2 for treatment of cancer

GANYMED PHARMACEUTICALS AG2 citations70
US8354104B2Jan 15, 2013

Monoclonal antibodies for treatment of cancer

GANYMED PHARMACEUTICALS AG3 citations63
US7429461B2Sep 30, 2008

Genetic products differentially expressed in tumors and use thereof

GANYMED PHARMACEUTICALS AG2 citations63
US11976130B2May 7, 2024

Antibodies against claudin 18.2 useful in cancer diagnosis

GANYMED PHARMACEUTICALS AG0 citations62
US10919974B2Feb 16, 2021

Antibodies for treatment of cancer expressing claudin 6

GANYMED PHARMACEUTICALS AG0 citations61
US9902778B2Feb 27, 2018

Cancer therapy using CLDN6 target-directed antibodies in vivo

GANYMED PHARMACEUTICALS AG1 citations61

SAHIN UGUR

12 patents

LUDWIG INST CANCER RES

7 patents

BIONTECH AG

5 patents

ASTELLAS PHARMA INC

4 patents

GANYMED PHARMACEUTICALS GMBH

3 patents

BIONTECH CELL & GENE THERAPIES GMBH

2 patents

BioNTech SE

2 patents

CORNELL RES FOUNDATION INC

1 patent

SLOAN KETTERING INST CANCER

1 patent

Showing the top 50 of 65 patents by PatentIndex Score.